Fundraising Fox
/Companies
Sign in

Mango Sciences Inc.

Boston, US · Founded 2019 · Delaware corporation · 6 known investors

Find your way into Mango Sciences Inc.

Sign up to see every warm intro you have to Mango Sciences Inc.

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Mango Sciences Inc. team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Mango Sciences works with healthcare providers in emerging markets to collect and analyze clinical patient data from underrepresented populations, building a base of real-world evidence and global health data. Its data analytics platform, paired with a patient affordability and accessibility initiative, aims to generate healthcare insights that improve patient access and care.

AI & Machine LearningBiotechData & InfrastructureDigital HealthHealthtech

Founders & leadership

Mango Sciences Inc. was founded in 2019 by Mohit Misra, Gavin, and Chitrang.

MMMohit Misra
Mohit MisraCo-Founder & CEOMohit Misra is a physician and trained health economist who has previously worked as a strategy consultant and an investor, with experience across healthcare at the intersection of data, technology, and medicine. He is the founder of Mango Sciences, which works to make cancer care more accessible and affordable in emerging markets.
GGavin
GavinFounder
C
Chitrang
HKHanif Khalak
Hanif KhalakHanif Khalak is a technology executive with expertise in data infrastructure, artificial intelligence, machine learning, and healthcare technology platforms. He founded Mango Sciences, which builds a clinical data analytics platform for healthcare providers in emerging markets to improve patient access and care.
AAndy
AndyExecutiveAndy Liu is Chief Commercial Officer of Mango Sciences. He previously served as President of Asia Pacific and China for IQVIA, overseeing data analytics and commercial businesses across 17 countries, and held executive roles including CEO at multiple healthcare technology companies; earlier in his career he worked in senior positions at Merck and UCB Pharma, and as an operator for TPG-backed portfolio companies in healthcare and life sciences.
RRam
RamHead of Strategic Finance
NS
Navinder Singh SacharVP of Commercial MENA & APAC
RRRohith Raj
Rohith RajChief People Strategist
HS
Hoicine Sidi-SaidNamed on SEC filing
SE
Sara EapenNamed on SEC filing
VC
Vamsi Chandra KasivajjalaNamed on SEC filing

Board

SRSanjay Reddy
Sanjay ReddyBoard directorPartner at Unlock Venture Partners

Investors · 6

Octopus Ventureslisted by Octopus VenturesLondon · $130K – $1.3M

How we know: octopusventures.com · Not right? Tell us

Swordfish Investmentslisted by Swordfish InvestmentsLondon

How we know: Swordfish Investments's portfolio page · Not right? Tell us

Unlock Venture Partnerslisted by Unlock Venture PartnersSeattle

How we know: Unlock Venture Partners's portfolio page · the VCSheet dataset · Not right? Tell us

BECO CapitalreportedDubai

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Incisive VenturesreportedSeattle · $250K – $500K

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$2.7M disclosed across 1 round · 2020

▶$2.7MraisedJan 2020 · 23 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Hoicine Sidi-SaidDirector
  • Sara EapenExecutive Officer
  • Sanjay ReddyDirector
  • Mohit MisraExecutive Officer, Director, Promoter
  • Vamsi Chandra KasivajjalaDirector, Promoter
Offering amount
$7M
Amount sold
$2.7M
First sale
Jan 2020
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

MangoMango Micro makes the M6, an automated microbial colony counting system that uses machine learning to deliver CFU counts and digitize quality-control labs. It targets regulated manufacturing environments with features like 21 CFR Part 11 compliance, LIMS integration, and non-destructive testing across six hot-swappable test bays.
MangoceuticalsMangoceuticals, Inc. is a publicly traded company; this page is an investor relations sign-up form for receiving company news and alerts. The page does not describe the company's products or business in concrete terms.

Companies working in the same space as Mango Sciences Inc..

Frequently asked questions

What does Mango Sciences Inc. do?
Mango Sciences works with healthcare providers in emerging markets to collect and analyze clinical patient data from underrepresented populations, building a base of real-world evidence and global health data. Its data analytics platform, paired with a patient affordability and accessibility initiative, aims to generate healthcare insights that improve patient access and care.
Who founded Mango Sciences Inc.?
Mango Sciences Inc. was founded by Mohit Misra, Gavin, Chitrang in 2019.
Who are Mango Sciences Inc.'s investors?
Mango Sciences Inc.'s investors include Kube VC, Octopus Ventures, Swordfish Investments, Unlock Venture Partners, BECO Capital, Incisive Ventures.
How much funding has Mango Sciences Inc. raised?
Mango Sciences Inc. has disclosed $2.7M raised across 1 round.
Where is Mango Sciences Inc. headquartered?
Mango Sciences Inc. is headquartered in Boston, US.